Spyre Therapeutics (SYRE) FCF Margin Growth (1y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 88,864.00 |
| Mar 31, 2023 | -697,508.00 |
| Dec 31, 2022 | -1.03 Mn |
| Sep 30, 2022 | -851,409.00 |
| Jun 30, 2022 | -332,859.00 |
| Jun 30, 2018 | 2,308.00 |
| Mar 31, 2018 | 8,208.00 |
| Dec 31, 2017 | -1,206.00 |
| Sep 30, 2017 | -8,266.00 |
| Jun 30, 2017 | -6,102.00 |
| Mar 31, 2017 | -11,626.00 |
| Dec 31, 2016 | -30,386.00 |
| Sep 30, 2016 | -14,614.00 |
| Jun 30, 2016 | -23,118.00 |